Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May 27:2015:1713.

Seborrhoeic dermatitis of the scalp

Affiliations

Seborrhoeic dermatitis of the scalp

Luigi Naldi et al. BMJ Clin Evid. .

Abstract

Introduction: Seborrhoeic dermatitis affects a variable proportion of the general population, ranging from 3% to 10%. Malassezia yeast species (previously referred to as Pityrosporum) are thought to be the responsible organisms, and cause inflammation by still poorly defined mechanisms. Seborrhoeic dermatitis tends to relapse after treatment.

Methods and outcomes: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of topical treatments for seborrhoeic dermatitis of the scalp in adults? We searched: Medline, Embase, The Cochrane Library, and other important databases up to November 2013 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).

Results: We found 14 studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.

Conclusions: In this systematic review we present information relating to the effectiveness and safety of the following interventions: bifonazole, ciclopirox, ketoconazole, pyrithione zinc, selenium sulfide, tar shampoo, terbinafine, and topical corticosteroids (betamethasone valerate, clobetasol propionate, clobetasone butyrate, hydrocortisone, mometasone furoate).

PubMed Disclaimer

References

    1. National Center for Health Statistics. Skin conditions and related need for medical care among persons 1-74 years. United States, 1971-1974. (DHEW publication no. 79-1660). November 1978. Available at http://www.cdc.gov/nchs/data/series/sr_11/sr11_212.pdf (last accessed 19 February 2015). - PubMed
    1. Coopman SA, Johnson RA, Platt R, et al. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993;328:1670–1674. - PubMed
    1. Bettley FR, Marten RH. Unilateral seborrhoeic dermatitis following a nerve lesion. AMA Arch Derm 1956;73:110–115. - PubMed
    1. Wilson CL, Walshe M. Incidence of seborrhoeic dermatitis in spinal injury patients. Br J Dermatol 1988;119(suppl 33):48.
    1. Tager A. Seborrhoeic dermatitis in acute cardiac disease. Br J Dermatol 1964;76:367–369. - PubMed

Publication types

MeSH terms